A “S−N+∼I− pathway” (S−: anionic surfactant, N+: cationic amino group and I: inorganic species) for the synthesis of mesoporous silica has been developed by using 3-aminopropyltriethoxysilane (APS) as a co-structure directing agent (CSDA), which can interact with the anionic head group in the surfactant (SDA). Thus synthesized mesoporous silica has been designated as AMS (Anionic-surfactant-templated Mesoporous Silica). Removal of the anionic surfactant by extraction led to the functionalized AMS containing amino groups on the silica surface. Amino-functionalized AMS using 3-aminopropyltriethoxysilane (APS) and lauric acid sodium salt (LAS) as CSDA and SDA, respectively, was synthesized with varying proportions of APS in the silica sources (x-APS-AMS, where x is the proportion of APS in the silica sources, x = 0.1–0.6). In 0.4-APS-AMS, the content of amino groups derived from APS estimated by CHN elemental analysis and the argentometric titration was 2.36 and 2.24 mmol g−1, respectively, suggesting that almost all the aminopropyl moieties were on the surfaces in contrast to the MCM-41 type materials synthesized with a cationic surfactant. Thus obtained amino-functionalized AMS via the anionic surfactant templating route shows a higher adsorption capacity for Co2+ cations than amino-functionalized MCM-41 prepared by the direct co-condensation method via a conventional cationic templating route. There was also a marked difference in the activity for the Knoevenagel reaction between amino-functionalized AMS and MCM-41, indicating a significant difference in the state of aminopropyl moieties exposed to the surfaces.
No takes yet. Share an insight, caveat, or question.
Yokoi et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: